Feasibility Study of a Remote Behavioral Dietary Intervention in Patients With Early to Intermediate AMD: Glucose Lowering for Vision Extension

Starting soon · Not applicable

Conditions studied: Age-Related Macular Degeneration

In brief

The primary goal of the study is to test dietary intervention at glycemic control and carotenoid levels in participants with intermediate age-related macular degeneration.

Key facts

Study ID

NCT07605468

Run by

Stanford University

People needed

32

Starts

2026-06-01

Expected to finish

2028-06-01

Last updated by the study team

2026-05-26

Who can join

Age: 55 and older, up to 75. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Diagnosis of early to intermediate AMD with no history of retinal geographic atrophy (cRORA) or exudative disease
• Eating a diet less healthy than average (Healthy Eating Index [HEI] score <61) based on 3 24-hour dietary recalls
• Access to a computer or smart phone for use in the behavioral meetings (we will provide loaners for those lacking a smart phone
• Because the initial questionnaires (ASA24), surveys and informed consent will be on line and in English, only individuals with fluency in English will be included. (They do not need to list English as their primary language.)

You may not qualify if…

• HbA1c greater than 6.5%,
• Diabetes or medications used to treat diabetes or obesity (including GLP1 agonists, metformin, glyburide
• Use of statins, niacin or other lipid/cholesterol modifying medications
• Recent cancer (within past 3 years)
• Other retinal or ocular pathology (other than pseudophakia and/or refractive error (between -8 to +8 diopter spherical equivalence)

Where it is running

• University of California, Los Angeles — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.